Log in to save to my catalogue

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-se...

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-se...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2555112634

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Due to trisomy of chromosome 21 and the resultant extra copy of the amyloid precursor protein gene, nearly all adults with Down syndrome develop Alzheimer's disease pathology by the age of 40 years and are at high risk for dementia given their increased life expectancy compared with adults with Down syndrome in the past. We aimed to compare CSF bio...

Alternative Titles

Full title

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2555112634

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2555112634

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(21)00139-3

How to access this item